Interleukins As a Marker of Inflammation in Diabetic Foot Syndrome and Type 2 Diabetes Mellitus

Kaleli, Süleyman; Varım, Ceyhun; Nalbant, Ahmet; Yazar, Hayrullah; Akdoğan, Mehmet

DSpace Home
→
Fakülteler / Faculties
→
Tıp Fakültesi
→
Dahili Tıp Bilimleri / Internal Medıcal Scıences
→
Makale Koleksiyonu
→
View Item

dc.contributor.authors	Kaleli, S; Varim, C; Nalbant, A; Yazar, H; Akdogan, M;
dc.date.accessioned	2020-02-27T08:28:02Z
dc.date.available	2020-02-27T08:28:02Z
dc.date.issued	2019
dc.identifier.citation	Kaleli, S; Varim, C; Nalbant, A; Yazar, H; Akdogan, M; (2019). Interleukins As a Marker of Inflammation in Diabetic Foot Syndrome and Type 2 Diabetes Mellitus. BEZMIALEM SCIENCE, 7, 7-1
dc.identifier.issn	2148-2373
dc.identifier.uri	https://doi.org/10.14235/bas.galenos.2017.2077
dc.identifier.uri	https://hdl.handle.net/20.500.12619/66025
dc.description.abstract	Conclusion: According to our results, IL-12 P70, IL-17 and IL-18 can be used as biomarkers for diabetic foot. Further studies arc needed to show the role of IL-12 P70, IL-17 and IL-18 levels as a biomarker in chronic inflammatory diseases.
dc.language	English
dc.publisher	BEZMIALEM VAKIF UNIV
dc.subject	General & Internal Medicine
dc.title	Interleukins As a Marker of Inflammation in Diabetic Foot Syndrome and Type 2 Diabetes Mellitus
dc.type	Article
dc.identifier.volume	7
dc.identifier.startpage	1
dc.identifier.endpage	7
dc.contributor.department	Sakarya Üniversitesi/Tıp Fakültesi/Temel Tıp Bilimleri Bölümü
dc.contributor.saüauthor	Kaleli, Süleyman
dc.contributor.saüauthor	Varım, Ceyhun
dc.contributor.saüauthor	Nalbant, Ahmet
dc.contributor.saüauthor	Yazar, Hayrullah
dc.contributor.saüauthor	Akdoğan, Mehmet
dc.relation.journal	BEZMIALEM SCIENCE
dc.identifier.wos	WOS:000499481600002
dc.identifier.doi	10.14235/bas.galenos.2017.2077
dc.contributor.author	Kaleli, Süleyman
dc.contributor.author	Varım, Ceyhun
dc.contributor.author	Nalbant, Ahmet
dc.contributor.author	Yazar, Hayrullah
dc.contributor.author	Akdoğan, Mehmet